Semax in particular has a consistent pattern of reports that the focus effect blunts with continuous daily use and returns after time off
While BPC-157 is still being studied and is not yet a standard therapy, we closely monitor advancements in peptide therapies and regenerative medicine to ensure our patients have access to the most effective and evidence-based options available
Dihexa operates at a deeper, more structural level
Ahangarzadeh S, Kanafi MM, Hosseinzadeh S, Mokhtarzadeh A, Barati M, Ranjbari J, et al
Predrag Sikiri, Professor at the University of Zagreb, has been a leading contributor to research on the stable gastric pentadecapeptide BPC-157